IFP Advisors, Inc - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 62 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,528
-77.4%
1,735
-50.0%
0.00%
Q2 2023$20,074
+44.8%
3,470
+100.0%
0.00%
-100.0%
Q1 2023$13,863
+98921.4%
1,7350.0%0.00%
Q4 2022$14
-99.9%
1,7350.0%0.00%
Q3 2022$14,0000.0%1,7350.0%0.00%
Q2 2022$14,000
-50.0%
1,735
-50.0%
0.00%
Q1 2022$28,000
+16.7%
3,470
+100.0%
0.00%
Q4 2021$24,000
-36.8%
1,7350.0%0.00%
-100.0%
Q3 2021$38,000
+90.0%
1,735
+15.7%
0.00%
Q2 2021$20,0001,5000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders